Operaciones Fulgent Genetics, Inc. - FLGT CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.12 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Fulgent Genetics Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Cierre previo* | 39.45 |
Abrir* | 39.58 |
Cambio de 1 año* | -31.72% |
Rango del día* | 38.7 - 40.02 |
Rango de 52 semanas | 28.27-65.17 |
Volumen medio (10 días) | 239.24K |
Volumen medio (3 meses) | 5.00M |
Capitalización de mercado | 1.17B |
Ratio P/E | -100.00K |
Acciones en circulación | 29.70M |
Ingresos | 364.87M |
EPS | -0.90 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.56 |
Próxima fecha de resultados | Aug 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
May 30, 2023 | 39.45 | 0.05 | 0.13% | 39.40 | 40.06 | 38.99 |
May 26, 2023 | 39.30 | -0.66 | -1.65% | 39.96 | 39.96 | 38.46 |
May 25, 2023 | 39.88 | -0.10 | -0.25% | 39.98 | 40.09 | 38.67 |
May 24, 2023 | 40.24 | 0.56 | 1.41% | 39.68 | 40.25 | 38.41 |
May 23, 2023 | 40.18 | 1.17 | 3.00% | 39.01 | 41.46 | 39.01 |
May 22, 2023 | 40.05 | 2.97 | 8.01% | 37.08 | 40.17 | 37.08 |
May 19, 2023 | 37.70 | 2.07 | 5.81% | 35.63 | 38.22 | 35.63 |
May 18, 2023 | 35.54 | 0.56 | 1.60% | 34.98 | 35.96 | 34.97 |
May 17, 2023 | 35.65 | -0.32 | -0.89% | 35.97 | 36.24 | 34.81 |
May 16, 2023 | 36.00 | 0.01 | 0.03% | 35.99 | 36.24 | 35.38 |
May 15, 2023 | 36.42 | 1.31 | 3.73% | 35.11 | 36.43 | 35.11 |
May 12, 2023 | 35.46 | 1.16 | 3.38% | 34.30 | 35.46 | 33.87 |
May 11, 2023 | 34.36 | -0.20 | -0.58% | 34.56 | 35.00 | 33.94 |
May 10, 2023 | 35.18 | 0.96 | 2.81% | 34.22 | 35.38 | 33.88 |
May 9, 2023 | 33.86 | 1.28 | 3.93% | 32.58 | 34.68 | 32.39 |
May 8, 2023 | 33.07 | -0.20 | -0.60% | 33.27 | 33.28 | 31.99 |
May 5, 2023 | 33.86 | 2.56 | 8.18% | 31.30 | 34.16 | 30.61 |
May 4, 2023 | 28.47 | -0.51 | -1.76% | 28.98 | 29.23 | 28.23 |
May 3, 2023 | 29.29 | 0.43 | 1.49% | 28.86 | 30.05 | 28.85 |
May 2, 2023 | 29.01 | -0.47 | -1.59% | 29.48 | 29.49 | 28.87 |
Fulgent Genetics, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Wednesday, August 2, 2023 | ||
Hora (UTC) (UTC) 10:59 | País US
| Evento Q2 2023 Fulgent Genetics Inc Earnings Release Q2 2023 Fulgent Genetics Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Hora (UTC) (UTC) 21:00 | País US
| Evento Q3 2023 Fulgent Genetics Inc Earnings Release Q3 2023 Fulgent Genetics Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 618.968 | 992.584 | 421.712 | 32.528 | 21.351 |
Ingresos | 618.968 | 992.584 | 421.712 | 32.528 | 21.351 |
Coste de los ingresos, total | 252.067 | 215.533 | 89.807 | 14.107 | 10.697 |
Beneficio bruto | 366.901 | 777.051 | 331.905 | 18.421 | 10.654 |
Gastos totales de explotación | 440.441 | 316.631 | 135.908 | 32.956 | 26.421 |
Gastos de venta/general/administración Gastos, total | 149.992 | 75.171 | 30.167 | 12.312 | 10.19 |
Investigación y desarrollo | 28.91 | 24.219 | 11.58 | 6.537 | 5.534 |
Ingresos de explotación | 178.527 | 675.953 | 285.804 | -0.428 | -5.07 |
Ingresos por intereses (gastos), netos No operativos | 5.498 | 1.347 | 1.526 | 0.837 | 0.434 |
Ingresos netos antes de impuestos | 184.025 | 677.3 | 287.33 | 0.409 | -4.636 |
Ingresos netos después de impuestos | 141.923 | 502.505 | 214.798 | 0.366 | -4.672 |
Beneficio neto antes de partidas extra. Elementos | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Total de partidas extraordinarias | 0 | ||||
Ingresos netos | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Ajuste por dilución | |||||
Beneficio neto diluido | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Promedio ponderado de acciones diluidas | 30.964 | 30.976 | 24.056 | 18.709 | 17.978 |
BPA diluido sin partidas extraordinarias | 4.63128 | 16.3793 | 8.9088 | -0.02197 | -0.31188 |
BPA normalizado diluido | 4.70538 | 16.3793 | 9.0441 | -0.02197 | -0.31188 |
Equity In Affiliates | 0 | 3.734 | -0.488 | -0.777 | -0.935 |
Dividends per Share - Common Stock Primary Issue | |||||
Gastos (ingresos) extraordinarios | 2.975 | 4.354 | |||
Depreciation / Amortization | 6.497 | 1.708 | |||
Intereses menores | 1.48 | 1.125 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 66.168 | 67.704 | 105.655 | 125.341 | 320.268 |
Ingresos | 66.168 | 67.704 | 105.655 | 125.341 | 320.268 |
Coste de los ingresos, total | 47.357 | 54.717 | 59.56 | 60.065 | 77.725 |
Beneficio bruto | 18.811 | 12.987 | 46.095 | 65.276 | 242.543 |
Gastos totales de explotación | 90.992 | 104.256 | 105.303 | 112.547 | 118.335 |
Gastos de venta/general/administración Gastos, total | 31.885 | 39.046 | 36.125 | 41.106 | 33.715 |
Investigación y desarrollo | 9.782 | 8.509 | 7.507 | 6.905 | 5.989 |
Ingresos de explotación | -24.824 | -36.552 | 0.352 | 12.794 | 201.933 |
Ingresos por intereses (gastos), netos No operativos | 3.775 | 3.09 | 1.405 | 0.958 | 0.045 |
Ingresos netos antes de impuestos | -21.049 | -33.462 | 1.757 | 13.752 | 201.978 |
Ingresos netos después de impuestos | -15.849 | -24.076 | 1.343 | 11.099 | 153.557 |
Equity In Affiliates | 0 | 0 | 0 | ||
Beneficio neto antes de partidas extra. Elementos | -15.34 | -23.832 | 1.719 | 11.537 | 153.979 |
Ingresos netos | -15.34 | -23.832 | 1.719 | 11.537 | 153.979 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -15.34 | -23.832 | 1.719 | 11.537 | 153.979 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -15.34 | -23.832 | 1.719 | 11.537 | 153.979 |
Beneficio neto diluido | -15.34 | -23.832 | 1.719 | 11.537 | 153.979 |
Promedio ponderado de acciones diluidas | 29.536 | 29.62 | 30.867 | 31.189 | 31.24 |
BPA diluido sin partidas extraordinarias | -0.51937 | -0.80459 | 0.05569 | 0.36991 | 4.92891 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.51937 | -0.80516 | 0.05829 | 0.44485 | 4.92891 |
Intereses menores | 0.509 | 0.244 | 0.376 | 0.438 | 0.422 |
Depreciation / Amortization | 1.968 | 2.01 | 2.006 | 1.575 | 0.906 |
Gastos (ingresos) extraordinarios | -0.026 | 0.105 | 2.896 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 627.873 | 611.96 | 523.616 | 37.079 | 39.543 |
Efectivo e inversiones a corto plazo | 526.235 | 450.499 | 299.367 | 28.269 | 31.034 |
Efectivo y Equivalentes | 79.506 | 164.894 | 87.426 | 11.965 | 6.736 |
Inversiones a corto plazo | 446.729 | 285.605 | 211.941 | 16.304 | 24.298 |
Total deudores, neto | 90.544 | 145.011 | 204.076 | 7.245 | 7.489 |
Accounts Receivable - Trade, Net | 52.749 | 139.149 | 185.236 | 6.705 | 5.948 |
Prepaid Expenses | 6.814 | 4.244 | 3.682 | 1.288 | 0.706 |
Other Current Assets, Total | 4.28 | 12.206 | 16.491 | 0.277 | 0.314 |
Total Assets | 1386.05 | 1278.72 | 700.461 | 88.756 | 53.904 |
Property/Plant/Equipment, Total - Net | 98.921 | 71.163 | 41.027 | 8.607 | 6.446 |
Property/Plant/Equipment, Total - Gross | 142.202 | 90.793 | 51.947 | 16.597 | 12.332 |
Accumulated Depreciation, Total | -43.281 | -19.63 | -10.92 | -7.99 | -5.886 |
Long Term Investments | 326.648 | 485.047 | 132.502 | 42.819 | 7.898 |
Other Long Term Assets, Total | 38.941 | 23.739 | 3.316 | 0.251 | 0.017 |
Total Current Liabilities | 88.107 | 105.31 | 130.115 | 3.723 | 2.738 |
Accounts Payable | 23.093 | 20.494 | 26.488 | 1.581 | 1.313 |
Accrued Expenses | 24.981 | 17.689 | 8.713 | 1.753 | 1.425 |
Notes Payable/Short Term Debt | 20.638 | 21.284 | 15.019 | 0 | 0 |
Other Current Liabilities, Total | 18.452 | 45.511 | 79.895 | 0.389 | |
Total Liabilities | 119.368 | 119.971 | 131.074 | 5.979 | 2.752 |
Total Long Term Debt | 1.818 | 1.398 | 0 | 0 | 0 |
Deferred Income Tax | 9.836 | 0.725 | 0.377 | ||
Other Liabilities, Total | 16.417 | 5.407 | 0.582 | 2.256 | 0.014 |
Total Equity | 1266.69 | 1158.75 | 569.387 | 82.777 | 51.152 |
Common Stock | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 |
Additional Paid-In Capital | 486.585 | 501.908 | 418.065 | 146.058 | 114.203 |
Retained Earnings (Accumulated Deficit) | 801 | 657.597 | 150.881 | -63.429 | -63.018 |
Other Equity, Total | -20.903 | -0.759 | 0.438 | 0.146 | -0.035 |
Total Liabilities & Shareholders’ Equity | 1386.05 | 1278.72 | 700.461 | 88.756 | 53.904 |
Total Common Shares Outstanding | 29.438 | 30.16 | 28.178 | 21.483 | 18.172 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Goodwill, Net | 143.027 | 50.897 | |||
Intangibles, Net | 150.643 | 35.914 | |||
Current Port. of LT Debt/Capital Leases | 0.943 | 0.332 | |||
Capital Lease Obligations | 1.818 | 1.398 | |||
Minority Interest | 3.19 | 7.131 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 580.723 | 627.873 | 696.614 | 675.185 | 765.333 |
Efectivo e inversiones a corto plazo | 504.485 | 526.235 | 571.06 | 515.402 | 585.114 |
Efectivo y Equivalentes | 66.172 | 79.506 | 168.77 | 138.78 | 353.069 |
Inversiones a corto plazo | 438.313 | 446.729 | 402.29 | 376.622 | 232.045 |
Total deudores, neto | 64.641 | 90.544 | 109.646 | 138.422 | 164.911 |
Accounts Receivable - Trade, Net | 43.549 | 52.749 | 104.159 | 133.476 | 160.492 |
Prepaid Expenses | 6.875 | 6.814 | 8.399 | 9.419 | 4.696 |
Other Current Assets, Total | 4.722 | 4.28 | 7.509 | 11.942 | 10.612 |
Total Assets | 1376.77 | 1386.05 | 1405.78 | 1461.66 | 1465.59 |
Property/Plant/Equipment, Total - Net | 94.853 | 98.921 | 101.18 | 106.754 | 76.933 |
Property/Plant/Equipment, Total - Gross | 140.992 | 142.202 | 137.146 | 136.44 | 100.15 |
Accumulated Depreciation, Total | -46.139 | -43.281 | -35.966 | -29.686 | -23.217 |
Long Term Investments | 366.833 | 326.648 | 346.946 | 415.621 | 493.182 |
Other Long Term Assets, Total | 42.539 | 38.941 | 52.876 | 53.053 | 44.106 |
Total Current Liabilities | 81.939 | 88.107 | 102.522 | 127.527 | 141.714 |
Accounts Payable | 22.08 | 23.093 | 14.481 | 37.109 | 23.699 |
Accrued Expenses | 21.088 | 24.981 | 25.101 | 27.1 | 11.847 |
Notes Payable/Short Term Debt | 20.607 | 20.638 | 20.48 | 20.792 | 21.085 |
Other Current Liabilities, Total | 17.21 | 18.452 | 41.533 | 42.526 | 84.748 |
Total Liabilities | 112.319 | 119.368 | 128.735 | 156.897 | 159.458 |
Total Long Term Debt | 1.575 | 1.818 | 2.05 | 1.938 | 1.314 |
Deferred Income Tax | 9.836 | 9.836 | 1.826 | 1.73 | 1.21 |
Other Liabilities, Total | 14.498 | 16.417 | 17.987 | 19.734 | 8.392 |
Total Equity | 1264.45 | 1266.69 | 1277.05 | 1304.77 | 1306.13 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0 | 0.003 | 0.003 | 0.003 | 0.003 |
Additional Paid-In Capital | 495.981 | 486.585 | 477.814 | 504.066 | 507.046 |
Retained Earnings (Accumulated Deficit) | 785.66 | 801 | 824.832 | 823.113 | 811.576 |
Other Equity, Total | -17.193 | -20.903 | -25.602 | -22.417 | -12.493 |
Total Liabilities & Shareholders’ Equity | 1376.77 | 1386.05 | 1405.78 | 1461.66 | 1465.59 |
Total Common Shares Outstanding | 29.692 | 29.438 | 29.681 | 30.266 | 30.327 |
Goodwill, Net | 143.12 | 143.027 | 120.313 | 121.354 | 50.999 |
Intangibles, Net | 148.699 | 150.643 | 87.853 | 89.695 | 35.037 |
Long Term Debt | |||||
Minority Interest | 4.471 | 3.19 | 4.35 | 5.968 | 6.828 |
Current Port. of LT Debt/Capital Leases | 0.954 | 0.943 | 0.927 | 0.335 | |
Capital Lease Obligations | 1.575 | 1.818 | 2.05 | 1.938 | 1.314 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | 141.923 | 506.239 | 214.31 | -0.411 | -5.607 |
Efectivo de actividades de explotación | 253.52 | 538.577 | 140.628 | 5.517 | -0.675 |
Efectivo de actividades de explotación | 32.662 | 11.004 | 2.962 | 2.107 | 2.163 |
Deferred Taxes | -8.28 | -8.188 | -1.775 | -0.021 | 0.036 |
Partidas no monetarias | 85.21 | 32.198 | 16.582 | 4.757 | 3.977 |
Cash Taxes Paid | 56.193 | 237.069 | 20.612 | 0.02 | 0.001 |
Cambios en el capital circulante | 2.005 | -2.676 | -91.451 | -0.915 | -1.244 |
Efectivo de actividades de inversión | -261.314 | -546.548 | -326.438 | -29.046 | 0.95 |
Gastos de capital | -18.775 | -23.844 | -35.13 | -1.182 | -2.322 |
Otras partidas de flujo de caja de inversión, total | -242.539 | -522.704 | -291.308 | -27.864 | 3.272 |
Efectivo procedente de actividades de financiación | -77.141 | 85.405 | 261.251 | 28.775 | 0.015 |
Elementos de flujo de caja de financiación | 0 | 0.01 | 0 | ||
Total Cash Dividends Paid | |||||
Emisión (retiro) de acciones, neto | -76.074 | 85.406 | 246.232 | 28.775 | 0.015 |
Variación neta de la tesorería | -85.388 | 77.468 | 75.461 | 5.229 | 0.246 |
Efectos del cambio de divisas | -0.453 | 0.034 | 0.02 | -0.017 | -0.044 |
Emisión (amortización) de deuda, neta | -1.067 | -0.011 | 15.019 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.849 | 141.923 | 165.999 | 164.656 | 153.557 |
Cash From Operating Activities | -7.907 | 253.52 | 220.313 | 199.537 | 188.411 |
Cash From Operating Activities | 6.879 | 32.662 | 22.86 | 13.04 | 4.695 |
Deferred Taxes | -5.2 | -8.28 | -4.934 | -7.639 | -5.497 |
Non-Cash Items | 11.056 | 85.21 | 57.419 | 39.227 | 20.84 |
Cash Taxes Paid | 1.68 | 56.193 | 56.181 | 54.982 | 0.435 |
Changes in Working Capital | -4.793 | 2.005 | -21.031 | -9.747 | 14.816 |
Cash From Investing Activities | -4.354 | -261.314 | -168.715 | -213.004 | 0.688 |
Capital Expenditures | -2.034 | -18.775 | -14.053 | -8.618 | -5.36 |
Other Investing Cash Flow Items, Total | -2.32 | -242.539 | -154.662 | -204.386 | 6.048 |
Cash From Financing Activities | -1.101 | -77.141 | -47.548 | -12.086 | -0.934 |
Issuance (Retirement) of Stock, Net | -0.869 | -76.074 | -46.712 | -11.488 | -0.478 |
Issuance (Retirement) of Debt, Net | -0.232 | -1.067 | -0.836 | -0.598 | -0.456 |
Foreign Exchange Effects | 0.028 | -0.453 | -0.174 | -0.561 | 0.01 |
Net Change in Cash | -13.334 | -85.388 | 3.876 | -26.114 | 188.175 |
Financing Cash Flow Items | 0 | 0 | 0 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Hsieh (Ming) | Individual Investor | 28.0059 | 8318087 | -418399 | 2023-03-23 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 10.88 | 3231484 | -74863 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.6299 | 1375136 | -15583 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.8738 | 853549 | 55223 | 2023-03-31 | LOW |
Gao (Hanlin) | Individual Investor | 2.7569 | 818824 | -345 | 2023-05-17 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.6904 | 799081 | -6994 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3624 | 404664 | 9134 | 2023-03-31 | LOW |
Divisadero Street Capital Management, LP | Investment Advisor/Hedge Fund | 1.234 | 366500 | 366500 | 2023-03-31 | LOW |
Invesco Capital Management LLC | Investment Advisor | 1.189 | 353135 | 47683 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.0849 | 322215 | 16698 | 2023-03-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 1.0039 | 298175 | 240849 | 2023-03-31 | HIGH |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9372 | 278352 | 39185 | 2023-03-31 | LOW |
Argenta Asset Management SA | Investment Advisor | 0.7688 | 228357 | 228357 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.6408 | 190325 | -611 | 2023-03-31 | LOW |
Xie (Jian) | Individual Investor | 0.6205 | 184282 | -8293 | 2023-05-17 | MED |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6047 | 179606 | 30830 | 2023-03-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.5836 | 173334 | 107972 | 2023-03-31 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.5731 | 170225 | -39075 | 2023-03-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.5342 | 158657 | -8523 | 2023-03-31 | LOW |
Nuveen LLC | Pension Fund | 0.4969 | 147594 | 31050 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Fulgent Genetics, Inc. Company profile
Sobre Fulgent Genetics Inc
FULGENT GENETICS, INC. es una empresa de tecnología. La Compañía ofrece pruebas genéticas para proporcionar a los médicos información de diagnóstico clínicamente útil para mejorar la calidad de la atención al paciente. La Compañía ha desarrollado una plataforma tecnológica que integra algoritmos de supresión y comparación de datos, software de aprendizaje adaptativo, herramientas de diagnóstico genético avanzado y procesos de laboratorio integrados. Al 31 de diciembre de 2015, el menú de pruebas de la Compañía incluye aproximadamente 18,000 pruebas de un solo gen y más de 200 paneles específicos de enfermedades, de múltiples genes preestablecidos, que analizan colectivamente aproximadamente 7,500 enfermedades genéticas, incluidos varios tipos de cáncer, enfermedades cardiovasculares y neurológicas. Las sondas genéticas de la Compañía están diseñadas específicamente para generar datos genéticos que están optimizados para su software, lo que permite incorporar rápidamente nuevos genes en su menú de pruebas, desarrollar nuevos paneles de pruebas específicas de enfermedades y personalizar las pruebas para sus clientes.
El precio actual de la acción Fulgent Genetics, Inc. en tiempo real es 39.68 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Hingham Institution, Yduqs Participações S.A., Teck Resources Cl B, The Gap, Inc., Applied Materials y Marathon Digital Holdings, Inc. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Medical & Diagnostic Laboratories |
4978 Santa Anita Ave Ste 205
TEMPLE CITY
CALIFORNIA 91780-3600
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com